{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:17:11Z","timestamp":1790371031495,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,15]],"date-time":"2017-02-15T00:00:00Z","timestamp":1487116800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ijidonline.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.ijid.2017.02.010","type":"journal-article","created":{"date-parts":[[2017,2,21]],"date-time":"2017-02-21T00:30:19Z","timestamp":1487637019000},"page":"108-115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Pneumocystis pneumonia in patients with inflammatory or autoimmune diseases: Usefulness of lymphocyte subtyping"],"prefix":"10.1016","volume":"57","author":[{"given":"Yi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Ghannoum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7712-0866","authenticated-orcid":false,"given":"Chuntao","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxia","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huadong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuezhong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valery","family":"Lavergne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2017.02.010_bib0005","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1111\/imj.12599","article-title":"Consensus guidelines for diagnosis, prophylaxis and management of Pneumocystis jirovecii pneumonia in patients with haematological and solid malignancies, 2014","volume":"44","author":"Cooley","year":"2014","journal-title":"Intern Med J"},{"key":"10.1016\/j.ijid.2017.02.010_bib0010","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1093\/cid\/ciu094","volume":"58","author":"Masur","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2017.02.010_bib0015","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/bmt.2009.254","article-title":"Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective","volume":"44","author":"Tomblyn","year":"2009","journal-title":"Bone Marrow Transpl"},{"issue":"Suppl 4","key":"10.1016\/j.ijid.2017.02.010_bib0020","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/ajt.12119","article-title":"Pneumocystis pneumonia in solid organ transplantation","volume":"13","author":"Martin","year":"2013","journal-title":"Am J Transpl"},{"key":"10.1016\/j.ijid.2017.02.010_bib0025","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1093\/jac\/dkw157","article-title":"ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients","volume":"71","author":"Maertens","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2017.02.010_bib0030","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.4065\/82.9.1052","article-title":"Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials","volume":"82","author":"Green","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ijid.2017.02.010_bib0035","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/1753465810380102","article-title":"Update on the diagnosis and treatment of Pneumocystis pneumonia","volume":"5","author":"Carmona","year":"2011","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.ijid.2017.02.010_bib0040","series-title":"Mandell, Douglas and Bennett\u2019s principles and practice of infectious diseases","author":"Bennett","year":"2015"},{"key":"10.1016\/j.ijid.2017.02.010_bib0045","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1007\/s10156-012-0441-4","article-title":"Early diagnosis and treatment are crucial for the survival of Pneumocystis pneumonia patients without human immunodeficiency virus infection","volume":"18","author":"Asai","year":"2012","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.ijid.2017.02.010_bib0050","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jmii.2012.08.024","article-title":"Pneumocystis jiroveci pneumonia in immunocompromised patients: delayed diagnosis and poor outcomes in non-HIV-infected individuals","volume":"47","author":"Li","year":"2014","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.ijid.2017.02.010_bib0055","article-title":"Pneumocystis pneumonia in HIV-infected and immunocompromised non-HIV infected patients: a retrospective study of two centers in China","volume":"9","author":"Guo","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2017.02.010_bib0060","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1093\/jac\/dkw158","article-title":"ECIL guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients","volume":"71","author":"Maschmeyer","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2017.02.010_bib0065","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.diagmicrobio.2006.03.010","article-title":"Sensitivity and specificity of nested and real-time PCR for the detection of Pneumocystis jiroveci in clinical specimens","volume":"56","author":"Alvarez-Martinez","year":"2006","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijid.2017.02.010_bib0070","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.medmal.2014.01.007","article-title":"Groupe de recherche respiratoire en reanimation en o-h. Update on pulmonary Pneumocystis jirovecii infection in non-HIV patients","volume":"44","author":"Roux","year":"2014","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.ijid.2017.02.010_bib0075","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4065\/71.1.5","article-title":"Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy","volume":"71","author":"Yale","year":"1996","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ijid.2017.02.010_bib0080","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00296-008-0721-6","article-title":"Risk factors of Pneumocystis jeroveci pneumonia in patients with systemic lupus erythematosus","volume":"29","author":"Lertnawapan","year":"2009","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.ijid.2017.02.010_bib0085","first-page":"478","article-title":"Pneumocystis jirovecii pneumonia in patients with and without human immunodeficiency virus infection","volume":"41","author":"Su","year":"2008","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.ijid.2017.02.010_bib0090","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/infdis\/jir302","article-title":"Alveolar and blood T lymphocyte profiles in Pneumocystis jirovecii-positive patients: effects of HIV status","volume":"204","author":"Iriart","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2017.02.010_bib0095","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1440-1843.2009.01660.x","article-title":"Differences in the clinical characteristics of Pneumocystis jirovecii pneumonia in immunocompromised patients with and without HIV infection","volume":"15","author":"Enomoto","year":"2010","journal-title":"Respirology"},{"key":"10.1016\/j.ijid.2017.02.010_bib0100","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1080\/00365540410021180","article-title":"Risk factors analysis for Pneumocystis jiroveci pneumonia (PCP) in patients with haematological malignancies and pneumonia","volume":"36","author":"Roblot","year":"2004","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.ijid.2017.02.010_bib0105","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1378\/chest.118.3.712","article-title":"Peripheral blood CD4+ T-lymphocyte counts during Pneumocystis carinii pneumonia in immunocompromised patients without HIV infection","volume":"118","author":"Mansharamani","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.ijid.2017.02.010_bib0110","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1080\/00365540601150497","article-title":"Pneumocystis jiroveci pneumonia (PCP) in HIV-1-negative patients: a retrospective study 2002\u20132004","volume":"39","author":"Overgaard","year":"2007","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.ijid.2017.02.010_bib0115","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.jaci.2013.09.044","article-title":"Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experience","volume":"133","author":"Shearer","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ijid.2017.02.010_bib0120","first-page":"1186","article-title":"Risk factors for Pneumocystis carinii pneumonia in patients with polymyositis\/dermatomyositis or systemic lupus erythematosus","volume":"23","author":"Kadoya","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ijid.2017.02.010_bib0125","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1378\/chest.06-1467","article-title":"Serum indicators for the diagnosis of Pneumocystis pneumonia","volume":"131","author":"Tasaka","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.ijid.2017.02.010_bib0130","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1172\/JCI113000","article-title":"Study of the molecular mechanism of decreased liver synthesis of albumin in inflammation","volume":"79","author":"Moshage","year":"1987","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ijid.2017.02.010_bib0135","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/PL00021707","article-title":"Prediction of and prophylaxis against Pneumocystis pneumonia in patients with connective tissue diseases undergoing medium- or high-dose corticosteroid therapy","volume":"15","author":"Ogawa","year":"2005","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.ijid.2017.02.010_bib0140","doi-asserted-by":"crossref","first-page":"792","DOI":"10.3899\/jrheum.090843","article-title":"A survey of rheumatologists\u2019 practice for prescribing Pneumocystis prophylaxis","volume":"37","author":"Cettomai","year":"2010","journal-title":"J Rheumatol"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971217300565?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971217300565?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T01:54:28Z","timestamp":1536026068000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971217300565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":28,"alternative-id":["S1201971217300565"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2017.02.010","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pneumocystis pneumonia in patients with inflammatory or autoimmune diseases: Usefulness of lymphocyte subtyping","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2017.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}